Reporting of Harmonising Outcome Measures for Eczema (HOME) core outcome set instruments in randomized clinical trials for systemic treatments in atopic dermatitis

No abstract


Megan Lam, Phyllis I Spuls, Yael A Leshem, Louise A A Gerbens, Kim S Thomas, Bernd Arents, Tim Burton, Carsten Flohr, Aaron M Drucker


Journal: British Journal of Dermatology
Volume: 189
Issue: 4
Pages: 494 - 496
Year: 2023
DOI: 10.1093/bjd/ljad237

Further Study Information

Current Stage: Completed
Funding source(s): This work was supported through a UK National Institute for Health Research Career Development Fellowship held by C.F. (CDF-2014-07-037). Knowledge translation components of this work are funded by the Eczema Society of Canada and the Innovation Fund of the Alternate Funding Plan for the Academic Health Sciences Centres of Ontario.

Health Area

Disease Category: Skin

Disease Name: Atopic dermatitis

Target Population

Age Range: Unknown

Sex: Either

Nature of Intervention:

Stakeholders Involved

Study Type

- COS uptake study


- Systematic review

We included RCTs with publicly available results in 2018 or after in a living systematic review and network meta-analysis (NMA) of RCTs of systemic treatments for AD. For each included RCT, we evaluated data reported in trial registries, published conference abstracts and peer-reviewed publications.

Linked Studies

    No related studies

Related Links

    No related links